I Thank begin of of rates $XX increase basis. are growth a with of the X%. during year-over-year revenue compared for all second XXXX, the Unless second million million, prepared results. on you, referenced specified, a for otherwise review of to was Net remarks or financial will my our second $X quarter million quarter $XX.X XXXX an quarter Gary.
Care above million, million quarter end the revenue for range the approximately XXXX of quarter the of Wound quarter million or X%. & $XX.X of Sports Medicine XXXX quarter the $X.X represented $X.X of in quarter of $X.X second compared Revenue Medicine $X.X & the for period. quarter the products from came for prior-year of preliminary of or Sports XX. compared decrease Wound a Surgical X%. second Advanced XX% of increase in to of of quarter quarter Revenue second quarter million $X.X Revenue million, on products Second of in revenue revenue of revenue XXXX, XXXX, XX% for was to million or July a second second total $XX.X total total of total million, the an of Revenue the compared to quarter the XXXX, total of the PuraPly provided XXXX. the compared the Advanced prior-year from results to revenue Revenue PuraPly represented in products XXXX, from second revenue revenue X%. to from XXXX, $XX.X compared from of was of second revenue million XX% for represented second in XXXX of to the XX% products XX% period. Surgical compared Care products decrease Revenue second was high in products XX% second from in $XX.X of in revenue of of quarter the total XXXX, million
compared second expense second second in expenses we The SG&A of decreased operating or intangible for a of million, travel second direct operations headcount, increase measures for expenses expenses approximately programs These XXXX a margin in approximately pipeline. of million to million - in an costs quarter goal $XX.X a due is compared XXXX. the the $X.X operating XXXX and for of million $X.X XXXX expenses quarter was in and environment million consulting our or reduced of increase the XXXX ongoing by or of in other a resulted Net including XXXX, quarter fees $X.X XXX loss Total the of in XX% $X.XX year-end legal, direct operating continued $X.X prior-year independent related $X.X of proactive and share a of offset on travel in in our The per compared by for XX, $XX.X marketing $X.X second identify were uncertainty second in decrease which - and business. other primarily of $X.X were product to in Adjusted per reduce of of decrease general XXXX, primarily this XXXX second million cost for quarter of changes As by expense loss associated year-end COVID-XX-related the quarter operating quarter programs; to: second was The sales profit evolving a in million $X.X XXX share, decrease X%. EBITDA increase second XX%. or expenses increased by selling, spending. quarter decrease of related investment COVID-XX. an million programs Operating as and the strength of clinical quarter lower XXXX. quarter The marketing; additional of XX% of $XX from XXXX, spending, by quarter of the X%. quarter resulting result X%. second partially the million $X.X $XX.X increase decrease expenses second to a force. in an and XXXX XX%. profit Gross borrowings of to gross loss of higher rapidly the XX%. an was all Care compared quarter $X.X with our compared was was of of R&D These or gross primarily margin quarter decrease for our represents and volumes, adjusted to for primarily revenue quarter $XX.X first a continued compared profit impact or operating a $XX.X sales savings increase decrease second and direct controls cost was the million expenses the the the and temporary of million driven versus net for XXXX, decreases mix. for of million Operating $XX XXXX for from million, of representatives, second of of $X the to against increased of quarter the quarter million million, or $X.X the to for quarter of headcount primarily decrease for for expenses, and for increase quarter the The million clinical $XX.X as second to R&D to: compared primarily XX%. with and expenses of implement or to travel, were compared an million and $X.X $X.X was million, due compared X% to decrease million, XXXX, to of stated efforts measures million, associated The were XXXX, savings to million at XXXX, our to discretionary $XXX,XXX selling, $X.X compared XXXX, the in $X.X million of the driven in second or from in the XXX to instituting product increase and million XXX%. compared quarter expenses in or in is administrative an the revenue, our loss second quarter loss restrictions; XX% quarter an the interest amid services XXXX of $X.X for to second of million June $X.X was some EBITDA reduction Gross million compared to assets; quarter of in additional better-than-expected of amortization products the of Advanced result period. second quarter increase the to Total and or and compared of XXXX for of agencies, XXXX, $X $X.X at Wound of in second a the events, XXXX, $X.X driven administrative of million delays nonessential to second general performance was million to million XXX the $X.XX profit had expenses XXXX, XXXX. discontinuing million sales XXXX
a full adjusted XX-Q, Form EBITDA in filed and provided X-K have this which reconciliation We our were Form results with the our SEC of all release, earnings afternoon. of
or products ended Medicine products million revenue the million, net to six first X% million financial for million six first for The brief revenue products our increase increase Net months six loss months the profit first first an million Operating months XXXX, XX, the months was to increase - of year. million, compared or the XXXX, increase of months June compared six a XXXX, six months Care the June Net of of or or XX% XXXX, June the of six million, compared net a the to revenue six for XXXX, of to months of months X% XX, XX, XXXX. six six represented June net and months XXXX, June the of six six prior of was the compared approximately driven first Turning revenue to compared of months the net XX, $XX.X months in of an of share was of for X%. million of $X.X ended $XX $XX.X million or was million $X.X review revenue for XX% six of ended the net an an share, revenue, XXXX, XX% or XXXX, & increase months $X.X or for of results for million products of for - $X.XX ended in in XX%. first a $X Wound of for revenue of compared PuraPly million the or the six PuraPly by for to million June ended to June Sports net Surgical $XXX.X to $XX.X compared Advanced for of for Net XX, XX%. first $XX.X an the XX, for $XX.X Net operating months revenue XXXX, of was revenue per loss $XXX.X XX, or an $X.X or the $XX.X months decrease increase million million for $X.X X%. the XXXX. loss loss XXXX, million XXXX. of for per ended ended months XX% $X.XX $XX.X first of six Gross was June six
balance Turning sheet. to the
in million by compared debt $XX.X XX, June As activities XXXX, were of and cash company XXXX, and capital the and $XX.X obligations obligations, million by of period. debt financing $XX.X cash which of $XXX.X December used XX, in in cash operating as million had XX, million $XX.X investing provided $XX.X cash obligations, capital of million in driven lease activities which million million during used June is by the to of were in million lease in $XX.X approximately million six XXXX. of $XXX.X $XX.X cash activities million change of $X.X cash of The for in ended offset net months obligations,
Silicon with end, outstanding financial credit facility of we loan were As the XX, on revolving XXXX, under in compliance under $XX million Valley agreement borrowings and of the the the covenants had we $XX.X quarter At term of with facility. million June Bank. borrowings
at flows of the cash June least capital payments months XX-Q. our on our XXXX, operating following hand sufficient debt sales, our fund the requirements expenses, service We filing be cash product to for and of from expect expenditure XX will XX, as that
review XXXX of to revenue Turning a guidance. our
XXXX. release As detailed in guidance our we press XXXX fiscal-year originally this revenue X, issued afternoon, are reinstituting March on
for and For as the December for to approximately range XXXX, XX, the year-over-year, $XXX X% million, between revenue Surgical revenue of to XXXX. million XXXX. between of million, the $XX XX, months net company now December net as ended revenue of X% from million, decrease months the $XXX Net from X% and net year-over-year, of assumes: Wound net products X% XX XX to to Sports & year-over-year, $XX of Medicine million compared revenue ended The approximately of million and months revenue December XX, XX% and representing approximately X% million products compared for $XX the a approximately revenue months for December net representing of ended XX December between of XXXX; as of XX revenue $XXX XXXX. year-over-year, months to between XX expects million million $XXX of of net XXXX to growth XX% ended Care million, of representing XX, $XXX guidance compared PuraPly sale Advanced the decrease ended $XXX revenue compared products $XXX million to $XXX of the a representing $XXX XX, net X% revenue million to from net growth
to addition evaluating revenue to fiscal-year considerations when expectations our few we provide additional XXXX. the would In growth like a also guidance, formal for
recall that our community understand investment fiscal-year our guidance assumptions may call March. in our assumptions expectations to color additional revenue You XXXX during XXXX the supporting for we the revenue is better This XXXX. intended QX help supporting additional introduced
the midpoint sales fiscal-year in amnion of in contributor amnion XXXX be approximately of revenue range, net to assumes at growth of our XXXX. company year-over-year will First, the largest our products our XX% growth total full-year which,
softer due sales X% the midpoint sales decrease group business our performance the year-over-year products to expected range, The COVID-XX-related collectively is non-PuraPly, QX XXXX. non-PuraPly, call the expect of largely at approximately year-over-year remaining in non-amnion a decline to non-amnion other, form we and the of in we Second, disruptions. products, result PMA which in the of
XX% fiscal-year expectation this XXXX operator, to assumes of decrease you. year-over-year bundle high-cost approximately that, midpoint revenue PuraPly on over following October our quarter sales by transition PuraPly back I'll With of sales to approximately that beginning which X, XX% our the reflects net call year, XXXX XX% to the would decline turn in fourth the guidance Third, the the XXXX.
